serw-MX  [xml]  
 


    
 Categorias DeCS

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.477 Immunologic Factors .
D27.505.696.477.656 Immunosuppressive Agents .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.384 Antineoplastic Agents, Immunological .
E02 Therapeutics .
E02.095 Biological Therapy .
E02.095.465 Immunomodulation .
E02.095.465.425 Immunotherapy .
E02.095.465.425.450 Immunosuppression .
E05 Investigative Techniques .
E05.478 Immunologic Techniques .
E05.478.610 Immunosuppression .
 
 Termos
 Sinônimos e Históricos
Documentos
LILACS e MDL
 
Antineoplastic Agents .
Anticancer Agents .
Antineoplastic Drugs .
Antineoplastics .
Antitumor Agents .
Antitumor Drugs .
Cancer Chemotherapy Agents .
Cancer Chemotherapy Drugs .
Chemotherapeutic Anticancer Agents .
Chemotherapeutic Anticancer Drug .
Agents, Anticancer .
Agents, Antineoplastic .
Agents, Antitumor .
Agents, Cancer Chemotherapy .
Agents, Chemotherapeutic Anticancer .
Chemotherapy Agents, Cancer .
Chemotherapy Drugs, Cancer .
Drug, Chemotherapeutic Anticancer .
Drugs, Antineoplastic .
Drugs, Antitumor .
Drugs, Cancer Chemotherapy .
Antineoplastic and Immunosuppressive Agents .
Antineoplastics, Immunosuppressives .
1.00
 
Immunosuppressive Agents .
Immunosuppressants .
Agents, Immunosuppressive .
0.68
 
Immunosuppression .
Anti-Rejection Therapy .
Therapy, Anti-Rejection .
Therapy, Antirejection .
Anti Rejection Therapy .
Anti-Rejection Therapies .
Antirejection Therapies .
Immunosuppressions .
Antirejection Therapy .
0.67
 
Antineoplastic Agents, Immunological .
Antineoplastic MAbs .
Antineoplastics, Monoclonal Antibodies .
Antineoplastics, Monoclonal Antibody .
MAbs, Antineoplastic .
Monoclonal Antibodies, Antineoplastic .
Antibodies Antineoplastics, Monoclonal .
Antineoplastic Monoclonal Antibodies .
Immunological Antineoplastic Agents .
Monoclonal Antibodies Antineoplastics .
Monoclonal Antibody Antineoplastics .
0.61